Insilico Medicine and Bora Pharmaceuticals announce AI-driven drug discovery partnership›via news-medical.net
runtimewire.comInsilico's AI-discovered lung fibrosis drug enters Phase III6d ago· By Ryan Merket
0
Shared by @Medscape ↗
mdsc.pe3d ago
Shared by @rmcarpiano.medsky.social ↗
substack.com7d ago
Shared by @NASAWatch ↗
Redwire8d agoruntimewire.comInsilico's AI-discovered lung fibrosis drug enters Phase III
Orforglipron is an FDA-approved non-peptide oral GLP-1 pill, an alternative to injectable weight-loss drugs. Demand for GLP-1s has surged, but cost and injectable delivery have limited access. A CU Anschutz researcher is leading a clinical trial for orfor
news.cuanschutz.edu·Twitter Biohacking & Health·9d ago·8 min readMillions of people rely on statins – a medication used to lower cholesterol and reduce the risk of heart attack and stroke. But for some, the drugs come with an unwelcome trade-off: muscle pain, weakness and exercise intolerance that can make it difficult
healthsci.mcmaster.ca·Twitter Biohacking & Health·9d ago·4 min read
Shared by @HopkinsMedicine ↗
Healthline News RSS Feed10d ago
Shared by @folha.com ↗
www1.folha.uol.com.br12d ago
Shared by @mcbridetd.bsky.social ↗
medpagetoday.com13d ago
Shared by @DocAmen ↗
amenclinics.com13d ago
Shared by @Medscape ↗mdsc.pe14d ago
Shared by @paleofuture.bsky.social ↗
nytimes.com14d ago
Shared by @apnews.com ↗
apnews.com18d ago
Shared by @hempedification.bsky.social ↗
businessofcannabis.com18d ago
Shared by @apnews.com ↗apnews.com18d ago
Shared by @ansabio.bsky.social ↗
hubs.li21d ago
Manila Times
Fierce Biotech
